Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03663790 · ClinicalTrials.gov registry record · NA

Effects of Gait Retraining on Lower Extremity Biomechanics

A NA study of Knee Osteoarthritis, sponsored by George Mason University.

Recruiting
Registry status
NA
Development phase
51
Enrollment target
1
Study location

NCT03663790: Recruiting NA study of Knee Osteoarthritis, sponsored by George Mason University.

NCT03663790 is a NA study of Knee Osteoarthritis that is actively recruiting participants, run by George Mason University. The registered enrollment target is 51 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03663790, a NA study of Knee Osteoarthritis, is actively recruiting participants, sponsored by George Mason University.

RECRUITING
Registry status
NA
Development phase
51 participants
Enrollment target
1
Study location

Study Summary

The purpose of this proposed study is to investigate both the acute and chronic response of frontal plane knee moment after gait retraining and to assess the effects on the biomechanics of the contralateral side. Fifty-one patients diagnosed with tibiofemoral joint osteoarthritis (TFJ OA) will be recruited to participate in the proposed study. Participants will complete baseline trials to assess gait kinematic and kinetic parameters. Following baseline, each participant will perform six conditions of the foot progression gait or three conditions of the trunk lean gait modifications to determine which strategy is most effective in reducing frontal plane knee moment. Participants will then be randomized to either the control or experimental group based on their identified preferred strategy. Participants will complete eight gait retraining sessions using patient-specific gait modifications (tailored foot progression and tailored lateral trunk lean), or normal gait (control) during the training period. A fading feedback design will be implemented. Real-time haptic biofeedback will be provided on every step during the first two weeks and reduced by 25% every subsequent two weeks. No feedback will be provided during baseline and at testing sessions. Measures of pain and function will also be collected at all testing sessions. Variables of interest include ankle, knee, hip sagittal and frontal plane moments. In addition, sagittal and frontal plane impulse will also be assessed. Descriptive statistics will be calculated for foot progression angle, trunk lean angle, frontal and sagittal plane hip, knee, and ankle angles as well as moments. Descriptive statistics for frontal plane knee impulse will also be calculated. A multivariate analysis of variance (MANOVA) will be conducted to compare frontal plane knee moment, frontal plane knee impulse and the absolute sagittal plane moment will be compared across three groups at four different time points. Repeated measures analys

Primary Outcome

The knee adduction moment is a surrogate measure to evaluate knee joint loads.

Conditions Studied

Interventions

  • OTHER Foot Progression
  • OTHER Trunk Lean

Study Locations (1)

Virginia

  • Sports Medicine, Assessment, Research & Testing (SMART) Laboratory - Manassas

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2018-10-10
Est. Completion 2026-10-01
Phase NA
George Mason University

25 total trials

What NCT03663790 shows while recruiting

NCT03663790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Foot Progression is the first listed.

NCT03663790 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT03663790 about?

NCT03663790 is a clinical study titled "Effects of Gait Retraining on Lower Extremity Biomechanics". The purpose of this proposed study is to investigate both the acute and chronic response of frontal plane knee moment after gait retraining and to assess the effects on the biomechanics of the contralateral side. Fifty-one patients diagnosed with tibiofemoral joint osteoarthritis (TFJ OA) will be re...

What is the current status of trial NCT03663790?

This trial is currently recruiting. It is a NA study. The enrollment target is 51 participants. The study started on 2018-10-10. Estimated completion is 2026-10-01.

What conditions does trial NCT03663790 study?

This clinical trial studies the following conditions: Knee Osteoarthritis.

What interventions are being tested in trial NCT03663790?

The interventions under investigation include: Foot Progression (OTHER), Trunk Lean (OTHER).

Who is sponsoring clinical trial NCT03663790?

This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03663790 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03663790's enrollment target sits among peer trials

51 68th of 101 higher than 33 of 101 other Knee Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

  • NCT04838041 · 51 participants · Phase 2

    Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03663790, the US trial registry maintained by the National Library of Medicine. NCT03663790 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.